Catalyst Biosciences Inc (CBIO)

Catalyst Biosciences (CBIO) Financial Statements


Catalyst Biosciences Financial Overview

Catalyst Biosciences's market cap is currently ―. The company's EPS TTM is $0.375; its P/E ratio is 0.54; Catalyst Biosciences is scheduled to report earnings on May 4, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 794.00K$ 2.44M$ 2.30M
Gross Profit$ 0.00$ 0.00$ -4.00K$ -14.00K$ -8.00K
EBIT$ -4.88M$ -5.71M$ -14.70M$ -20.31M$ -25.23M
EBITDA$ -4.84M$ -5.65M$ -14.59M$ -20.20M$ -25.14M
Net Income Common Stockholders$ -4.88M$ 51.63M$ -14.54M$ -20.33M$ -25.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 23.09M$ 75.39M$ 34.82M$ 46.85M$ 64.53M
Total Assets$ 31.02M$ 83.37M$ 40.27M$ 55.66M$ 78.54M
Total Debt$ 381.00K$ 1.42M$ 1.91M$ 2.38M$ 2.39M
Net Debt$ -22.71M$ -73.98M$ -32.91M$ -44.47M$ -62.13M
Total Liabilities$ 1.64M$ 4.31M$ 13.19M$ 14.57M$ 17.80M
Stockholders Equity$ 29.38M$ 79.06M$ 27.08M$ 41.09M$ 60.74M
Cash Flow-
Free Cash Flow$ -7.28M$ -12.29M$ -12.05M$ -17.68M$ -22.09M
Operating Cash Flow$ -7.28M$ -12.29M$ -12.05M$ -17.68M$ -21.60M
Investing Cash Flow$ 0.00$ 52.87M$ 2.50M$ 2.87M$ 7.04M
Financing Cash Flow$ -45.03M$ 0.00$ 16.00K$ 0.00$ 98.00K
Currency in USD

Catalyst Biosciences Earnings and Revenue History

Catalyst Biosciences Debt to Assets

Catalyst Biosciences Cash Flow

Catalyst Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis